prof. dr. ir. Kathleen Claes
work address
De Pintelaan 185, geb. MRB2
9000 Gent
9000 Gent
ORCID iD
0000-0003-0841-73721 – 10 of 110
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- The genetic basis of undiagnosed muscular dystrophies and myopathies: results from 504 patients
- DNA diagnostics of hereditary hearing loss: a targeted resequencing approach combined with a mutation classification system
- An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
- Incorporating PARP-inhibitors into clinical routine: a tailored treatment strategy to tackle ovarian cancer
- Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
- BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers
- Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2